| Income Statement |
| Total Revenue | 393.50M |
|
| Revenues (USD) | 393.50M |
| Cost of Revenue | 226.20M |
| Gross Profit | 167.30M |
| Operating Expenses | 126.40M |
| Research and Development Expense | 15.20M |
| Selling, General and Administrative Expense | 51.80M |
| Operating Income | 40.90M |
| Interest Expense | 4.80M |
| Income Tax Expense | 200.00K |
| Net Income | 35.90M |
| Net Income Common Stock | 34.20M |
| Net Income Common Stock (USD) | 34.20M |
| Consolidated Income | 35.90M |
| Earnings per Basic Share | 2.19 |
| Earnings per Basic Share (USD) | 2.19 |
| Earnings per Diluted Share | 2.09 |
| Earning Before Interest & Taxes (EBIT) | 40.90M |
| Earning Before Interest & Taxes (USD) | 40.90M |
| Preferred Dividends Income Statement Impact | 1.70M |
| Weighted Average Shares | 15.60M |
| Weighted Average Shares Diluted | 17.20M |
| Balance Sheet |
| Cash and Equivalents | 608.90M |
| Cash and Equivalents (USD) | 608.90M |
| Investments | 471.50M |
| Trade and Non-Trade Receivables | 350.80M |
| Total Assets | 1.68B |
| Total Debt | 200.30M |
| Total Liabilities | 1.25B |
| Accumulated Retained Earnings (Deficit) | -1.61B |
| Accumulated Other Comprehensive Income | 400.00K |
| Shareholders Equity | 325.90M |
| Shareholders Equity (USD) | 325.90M |
| Total Debt (USD) | 200.30M |
| Deferred Revenue | 412.40M |
| Trade and Non-Trade Payables | 138.30M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 3.10M |
| Net Cash Flow from Financing | -3.70M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -81.00M |
| Capital Expenditure | -3.50M |
| Net Cash Flow from Investing | -86.60M |
| Net Cash Flow - Investment Acquisitions and Disposals | -83.10M |
| Net Cash Flow from Operations | 9.30M |
| Share Based Compensation | 12.90M |